{"id":"NCT04697888","sponsor":"Children's Mercy Hospital Kansas City","briefTitle":"Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease","officialTitle":"Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2013-04","primaryCompletion":"2018-11","completion":"2018-11","firstPosted":"2021-01-06","resultsPosted":"2021-03-12","lastUpdate":"2021-06-11"},"enrollment":2,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Parenteral Nutrition-related Hepatitis"],"interventions":[{"type":"DRUG","name":"Omegaven","otherNames":["IV Fish Oil Based Lipid Emulsion"]}],"arms":[{"label":"Overall Study","type":"EXPERIMENTAL"}],"summary":"To provide parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, OmegavenÂ®) to patients with liver disease (PNALD).","primaryOutcome":{"measure":"Disease Progression as Measured by Serum Levels of Hepatic Enzymes","timeFrame":"Up to 1 year","effectByArm":[],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":2},"commonTop":[]}}